GlassScriptPhysician profile
Ana Cornea
NPI 1275522195
$6,275.55
in general payments reported to CMS, 2019-2025
54 companies · $2,834 in 2025
The $2,834 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $179 · 2021: $336 · 2022: $940 · 2023: $1,072 · 2024: $808 · 2025: $2,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,714.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $625.73 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $577.93 | 2021-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $409.06 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $403.41 | 2022-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $394.17 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Cequr Corporation | $343.86 | 2023-2025 | Cequr Simplicity |
| Amgen INC. | $311.51 | 2021-2025 | Tepezza, Evenity, Prolia |
| Dexcom, INC. | $283.66 | 2022-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.54 | 2022-2025 | Jardiance |
| Medtronic, INC. | $214.88 | 2022-2025 | Minimed 780g |
| Amneal Pharmaceuticals LLC | $197.27 | 2021-2024 | Unithroid |
| Sanofi-Aventis U.S. LLC | $176.58 | 2021-2025 | |
| Sequel Med Tech, LLC | $160.36 | 2025 | Twiist |
| Bayer Healthcare Pharmaceuticals INC. | $135.47 | 2022-2025 | |
| Tandem Diabetes Care, INC. | $123.54 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $117.87 | 2022-2025 | Tymlos |
| Mannkind Corporation | $110.70 | 2025 | |
| Beta Bionics, INC. | $104.58 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Medtronic Minimed, INC. | $85.72 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $83.99 | 2019-2020 | |
| Ascendis Pharma Endocrinology INC | $81.67 | 2023-2025 | Yorvipath |
| Corcept Therapeutics | $78.93 | 2022-2025 | Korlym |
| Madrigal Pharmaceuticals | $74.75 | 2025 | Rezdiffra |
| Neurocrine Biosciences, INC. | $71.68 | 2025 | |
| Alexion Pharmaceuticals, INC. | $70.49 | 2022-2025 | Strensiq |
| Abbvie INC. | $63.32 | 2023-2025 | Synthroid |
| Pfizer INC. | $60.33 | 2023-2025 | |
| Intuity Medical INC | $52.84 | 2022 | |
| Lifescan, INC. | $52.52 | 2021-2022 | |
| Chiesi USA, INC. | $47.05 | 2025 | Juxtapid, Mycapssa |
| Ibsa Pharma INC. | $41.39 | 2022 | |
| Horizon Therapeutics Plc | $39.87 | 2023 | Tepezza |
| Merck Sharp & Dohme LLC | $38.44 | 2021-2022 | |
| Nevro Corp. | $35.74 | 2021-2023 | Senza |
| Astellas Pharma US INC | $34.82 | 2023-2024 | Veozah, Myrbetriq |
| Inogen, INC. | $23.91 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Kyowa Kirin, INC. | $23.56 | 2023 | Crysvita |
| Averitas Pharma INC. | $22.81 | 2025 | Qutenza |
| Eusa Pharma (US) LLC | $21.64 | 2022 | |
| Recordati_rare_diseases_inc. | $21.64 | 2022 | |
| Electromed, INC. | $21.24 | 2022 | |
| United Therapeutics Corporation | $21.17 | 2024 | Tyvaso |
| Evoke Pharma, INC. | $20.22 | 2025 | |
| Baxter Healthcare | $18.48 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.87 | 2020 | |
| Soleno Therapeutics, INC. | $16.44 | 2025 | Vykat Xr |
| Alvogen INC | $16.25 | 2024 | Teriparatide |
| Takeda Pharmaceuticals U.S.A., INC. | $16.23 | 2020 | |
| Echosens North America, INC. | $15.49 | 2025 | Fibroscan |
| Esperion Therapeutics, INC. | $15.27 | 2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $15.13 | 2024 | |
| Philips North America LLC | $13.56 | 2022 | |
| Ambu INC. | $13.52 | 2023 | |
| Janssen Pharmaceuticals, INC | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Cornea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.